Novo Nordisk A S

NONOF

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0000353278

SEC filings (opens in a new tab)

No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.

Other share classesNVO

Q4 2023 vs. Q3 2023

How the institutions holding Novo Nordisk A S changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of NONOF: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	2	2	0
Shares	44.9K	40.4K	−4.46K (−9.9%)
Value	$4.09M	$4.18M	+$89.3K (+2.2%)

New holders (1)

Institutions that held Novo Nordisk A S at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to NONOF in Q4 2023
Institution	Shares	Value	% of portfolio
GAMMA Investing LLC	258	$29.8K	0.01%

Sold out (1)

Institutions that held Novo Nordisk A S at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of NONOF in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Atlas Capital Advisors LLC	5,218	$476.4K